@article{TCR15196,
author = {Pina Ziranu and Francesco Atzori and Marco Puzzoni and Laura Demurtas and Giorgio Astara and Mario Scartozzi},
title = {Effective combinatorial immunotherapy for castration-resistant prostate cancer: new future chance?},
journal = {Translational Cancer Research},
volume = {6},
number = {Suppl 6},
year = {2017},
keywords = {},
abstract = {Prostate cancer (pCa) is the second most common non-cutaneous malignant neoplasm in men worldwide, with an estimated incidence of 1.1 million new cases per year. Furthermore, it is the fifth leading cause of cancer-related death, representing 6.6% of total male mortality (1).},
issn = {2219-6803}, url = {https://tcr.amegroups.org/article/view/15196}
}